Unusual setting of medical care Background:
Background
Sarcoma botryoides, also known as embryonal rhabdomyosarcoma (ERMS), is a subgroup of rhabdomyosarcoma (RMS), a malignant tumor arising from embryonic muscle cells. It is the most common soft tissue sarcoma in childhood and young adulthood, accounting for 4% to 6% of all malignancies in this age group [1] . This tumor typically presents as a "grape-like" tumor. It is usually reported as a vaginal tumor in the female reproductive tract of infants and rarely in the uterine cervix [2] .
ERMS of the uterine cervix usually occurs in women in their late teens and early 20s [3] . In this case, the malignancy occurred at a very young age, presenting with a protruding mass out of the vagina. This case report aimed to highlight the difficulties encountered in diagnosing and treating patients with sarcoma botryoides in a limited resources setting in Indonesia.
Case Report
A 3-year-old female patient was brought to the outpatient clinic of our hospital with the chief complaint of a protruding mass in her vagina for 7 months. The mass was initially small, and the patient was brought to the hospital only after realizing its rapid growth. From history taking, the mass resembled a bunch of grapes, with a tendency to bleed. Gynecologic examination showed a 10×10 cm multinodular solid mass with smooth surface protruding through the vaginal introitus ( Figure 1) . Chest x-ray revealed no metastases in the lungs. A tumor excision with biopsy was performed afterwards. Pathological analysis of the biopsy revealed a malignant spindle mesenchymal tumor, suspecting leiomyosarcoma with differential diagnosis of rhabdomyosarcoma. After the surgery, the patient was scheduled for follow-up monitoring. However, the patient did not come back to the hospital due to insufficient fund and no health insurance.
Three months after the first surgery, the patient came back with recurrent vaginal mass. This time, the patient was covered by national health insurance. Gynecologic examination showed identical characteristics with the previous tumor at the same location, only smaller in size (6×5 cm) (Figure 2) . A second chest x-ray was performed and revealed no metastases. In the second surgery, a wide excision with 2 cm of margin of healthy tissue was performed without intraoperative biopsy due to limited resources. Post-operative pathological examination showed malignant spindle mesenchymal tumor, suggesting a sarcoma botryoides finding. 
Discussion
Sarcoma botryoides may appear as abnormal vaginal bleeding, prolapsing mass through vagina, or abdominal-pelvic mass [4] . The major physical finding is the presence of a mass in the vagina. RMS should be suspected in women with an abnormal mass in the vagina that has great tendency to bleed [5] . A study of sarcoma patients in Norway showed the common symptoms of RMS were post-menopausal bleeding (31-46%), premenopausal abnormal uterine bleeding (27-34%), abdominal pain (4-13%), abdominal distension (8-17%), voiding problems (1-2%), and asymptomatic (1-2%) [6] .
Risk factors of sarcoma botryoides have been unclear, due to the low quantity of cervical sarcoma botryoides cases reported in the literature. Some literature reports mention the following risk factors: aging, certain race (African-American women have incidence of twice that as white American), more than 5 years usage of tamoxifen, and history of radioactive exposure. While the number of parity, menarche age, and menopause have not been found to affect RMS [7] . One study found that exposure to chemical agents, maternal age more than 30 years, low socio-economy status, and environment factors contributed to the incidence of RMS [8] .
Diagnosis of sarcoma botryoides is based on histopathology and post-surgery immunohistochemistry, although in some cases it is done by preoperative histopathology or intraoperative frozen section [9] . In our case, IHC evaluation revealed positive antidesmin antibody and positive anti-myogenin antibody. This finding was similar to a previous case report of sarcoma botryoides in a 17-month old infant, where IHC evaluation showed focal positivity for desmin and myogenin [2] .
The Intergroup Rhabdomyosarcoma Study Group (IRSG) protocol recommends staging and grouping of the tumor. Staging is determined by primary tumor location, tumor size, regional lymph node involvement, and the presence of metastasis. Grouping categorizes patients according to the extent of disease remaining after the initial surgical procedure(s) but before beginning chemotherapy and radiation therapy. The staging and grouping systems and the tumor histologic subtype are all used to make decisions about treatment [10] established due to the scarce number of cases. However, multiple approaches to treatment result in better prognosis [11] . Tumors in the RMS group have a greater tendency to have early recurrence, which makes adjuvant chemotherapy considered as a post-surgical treatment. Until now, the combination of both has been preferred [12] . Adjuvant chemotherapy was given to our patient after the second surgery due to recurrence of the tumor, indicated by growth of the tumor at the same location with identical characteristic, but smaller in size, at 3 months after the first surgery.
